Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Linical CoTSE:2183 40 EV-to-OCF is -1.26 as of Sep. 03, 2026. GuruFocus rates TSE:2183 with a GF Score™ of 40/100 and a GF Value™ of 円336.70 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 1,406 Biotechnology companies, Linical Co ranks worse than 63.23% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Linical Co's Enterprise Value is 円2,038 Mil.
Linical Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was 円-1,611 Mil. Therefore, Linical Co's EV-to-OCF for today is -1.26.
The historical rank and industry rank for Linical Co's EV-to-OCF or its related term are showing as below:
TSE:2183'
s EV-to-OCF Range Over the Past 10 Years
Min: -37.69 Med: 9.3 Max: 951.52
Current: -1.26
During the past 13 years, the highest EV-to-OCF of Linical Co was 951.52. The lowest was -37.69. And the median was 9.30.
TSE:2183's EV-to-OCF is ranked worse than 63.23% of 1406
companies
in the Biotechnology industry
Industry Median: -3.69
vs TSE:2183: -1.26
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Linical Co's share price for today is 円207.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Linical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円-147.413.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Linical Co EV-to-OCF Related Terms
Linical Co EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Linical Co's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2183 vs VRTX, REGN, MRNA: EV-to-OCF Comparison
For the Biotechnology subindustry, Linical Co's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Linical Co EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Linical Co's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Linical Co's EV-to-OCF falls into.
Linical Co's current Enterprise Value is 円2,038 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Linical Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was 円-1,611 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Linical Co (TSE:2183) has a EV-to-OCF of -1.26 as of Sep. 03, 2026. According to the industry distribution chart, Linical Co ranks #889 out of 1406 companies in the Biotechnology industry, placing it in the top 63.2%.
Is Linical Co's EV-to-OCF too high?
Linical Co's current EV-to-OCF is -1.26. Based on the distribution chart, Linical Co ranks #889 out of 1406 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Linical Co has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Linical Co's EV-to-OCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Linical Co ranks #889 out of 1406 companies for EV-to-OCF. This places Linical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Linical Co's current EV-to-OCF is -1.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Linical Co stock overvalued right now?
Based on GuruFocus' analysis, Linical Co (TSE:2183) is currently considered Possible Value Trap. The stock's GF Value™ is 円336.70, compared to a current price of 円207.00 — trading 38.5% below its estimated fair value. The current EV-to-OCF is -1.26. Linical Co's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Linical Co (TSE:2183), the current EV-to-OCF is -1.26 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Linical Co (TSE:2183) Overvalued in 2026?
Based on GuruFocus' analysis, Linical Co stock appears to be undervalued.
The current stock price of 円207.00 is trading 38.5% below its estimated GF Value™ of 円336.70.
GuruFocus considers Linical Co to be Possible Value Trap.
Key valuation signals for TSE:2183:
EV-to-OCF: -1.26
GF Value™: 円336.70 vs. price of 円207.00 (38.5% below fair value)
No single metric tells the full story. See the TSE:2183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2183 has been successfully added to your 
